NEWPORT BEACH, Calif.--(BUSINESS WIRE)--ROTH Capital Partners (ROTH), www.roth.com, a full service investment bank recognized for providing financing and advisory services to emerging growth companies worldwide, today announced that David S. Moskowitz, RPh. has joined the firm’s Healthcare Research team as a Senior Research Analyst covering the specialty pharmaceutical sector.

Mr. Moskowitz joins ROTH from Madison Williams where he was Senior Research Analyst and Head of Healthcare Research. Prior to that, he held senior leadership positions in equity research at FBR Capital Markets and Caris & Company. He is a registered pharmacist, and before entering the financial services industry, he was a pharmacist in various hospital and retail settings.

Since the beginning of 2010, ROTH has assisted Healthcare clients in raising over $1 billion in approximately 50 transactions. ROTH’s Healthcare clients cover a broad spectrum of sectors including companies engaged in the clinical development of new therapeutic compounds, drug discovery techniques, medical technologies and devices.

“We are excited to welcome David to ROTH’s Healthcare team as we continue to broaden our presence and breadth of coverage in Biotechnology, Specialty Pharmaceuticals and Medical Devices,” said Byron Roth, CEO of ROTH Capital Partners. “We are focused on assisting our clients in raising the capital that enables their continued innovation and advising our clients in determining appropriate strategic options. David’s relationships with innovative companies and the investor community are a great fit with Roth and create a very unique opportunity to continue the exceptional momentum of our healthcare practice," continued Mr. Roth.

Mr. Moskowitz said, “I am excited to join the seasoned team of professionals at ROTH. The firm’s Healthcare franchise has very quickly become a leader in financing the emerging life sciences sector, and the caliber of ROTH’s Research and the breadth of its coverage universe is well-respected in the industry.”

Mr. Moskowitz holds a BS in Pharmacy from Rutgers University and an MBA in Finance and Pharmaceutical Industry Studies from Fairleigh Dickinson University.

About Roth Capital Partners, LLC:

ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on identifying opportunities for institutional investors in U.S.-listed equity securities of companies based in the U.S. and China. Headquartered in Newport Beach, CA, with offices throughout the U.S., Hong Kong and a Shanghai Representative Office, the employee-owned firm provides analytical research, trading, capital raising, and business combination advisory services. ROTH seeks to implement innovative financing strategies to efficiently meet the liquidity and valuation requirements of both its corporate and institutional investor clients.

Contacts